Nomura Q1 Net Income Surges 39% to ¥145.6B on Record Wholesale and Wealth Management
NMR sits 46% above its 52-week low of $6.59.
Summary
Nomura Holdings reported Q1 FY2027 net income of ¥145.6 billion, up 39% year-on-year, with record performances across Wealth Management, Investment Management, and Wholesale. ROE reached 15.4%, exceeding the 2030 target range.
Key Events · Earnings and Guidance · NMR
-
Q1 Net Income ¥145.6B, +39% YoY
Net income attributable to shareholders rose 39% year-on-year to ¥145.6 billion (US$895 million), driven by record performances in Wholesale and Wealth Management.
-
ROE 15.4% Exceeds 2030 Target
Annualized return on equity reached 15.4%, already above the 10-12% or more target set for 2030, reflecting strong profitability and capital efficiency.
-
Wholesale Record Revenue and Pretax Income
Wholesale net revenue of ¥369.1 billion and pretax income of ¥93.3 billion were both records, with Equities driving Global Markets and Investment Banking exceeding ¥50 billion in quarterly revenue for the first time.
-
Wealth Management Recurring Revenue at All-Time High
Recurring revenue, recurring revenue assets, and net inflows all hit records; recurring revenue cost coverage ratio improved to 76%.
Analysis · NMR · Finance
Nomura delivered its strongest first quarter in years, with net income jumping 39% year-on-year to ¥145.6 billion. Every major division hit records: Wealth Management recurring revenue and assets reached all-time highs, Investment Management assets under management climbed to ¥156 trillion, and Wholesale posted record net revenue and pretax income. ROE of 15.4% already exceeds the upper end of the company's 2030 target range, signaling the transformation strategy is working ahead of schedule. The results reinforce the bullish narrative from the May 2026 record full-year earnings and raised 2030 targets, showing momentum is accelerating rather than fading.
At the time of this filing, NMR was trading at $9.63 on NYSE in the Finance sector, with a market capitalization of approximately $27.6B. The 52-week trading range was $6.59 to $10.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.